These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 20136851)

  • 1. Pediatric interventional cardiology in the United States is dependent on the off-label use of medical devices.
    Sutherell JS; Hirsch R; Beekman RH
    Congenit Heart Dis; 2010; 5(1):2-7. PubMed ID: 20136851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in paediatric interventional cardiology since 2000.
    Abadir S; Sarquella-Brugada G; Mivelaz Y; Dahdah N; Miró J
    Arch Cardiovasc Dis; 2009; 102(6-7):569-82. PubMed ID: 19664577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The off-versus on-label use of medical devices in interventional cardiovascular medicine?: Clarifying the ambiguity between regulatory labeling and clinical decision making, part III: structural heart disease interventions.
    Holzer R; Hijazi Z
    Catheter Cardiovasc Interv; 2008 Nov; 72(6):848-52. PubMed ID: 19006259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Off-label does not mean off-base.
    Kaufman JA
    J Vasc Interv Radiol; 2008 Jul; 19(7):970-1. PubMed ID: 18589309
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathways to approval of pediatric cardiac devices in the United States: challenges and solutions.
    Beekman RH; Duncan BW; Hagler DJ; Jones TK; Kugler JD; Moore JW; Jenkins KJ;
    Pediatrics; 2009 Jul; 124(1):e155-62. PubMed ID: 19564262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shunt reduction with a fenestrated Amplatzer device.
    Kretschmar O; Sglimbea A; Corti R; Knirsch W
    Catheter Cardiovasc Interv; 2010 Oct; 76(4):564-71. PubMed ID: 20882662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The "art" of medicine and the "smokescreen" of the randomized trial off-label use of vascular devices.
    Ansel GM; Jaff MR
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):998-1002. PubMed ID: 19021289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcatheter closure of secundum atrial septal defect using the Amplatzer Septal Occluder: initial results of a single medical center in Taiwan.
    Lin MC; Fu YC; Jan SL; Lin WW; Chu KH; Ting CT; Chen YT; Chi CS
    Acta Paediatr Taiwan; 2005; 46(1):17-23. PubMed ID: 16302572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of the 2006 Food and Drug Administration Circulatory System Devices Panel meeting on drug-eluting stent thrombosis.
    Pinto Slottow TL; Waksman R
    Catheter Cardiovasc Interv; 2007 Jun; 69(7):1064-74. PubMed ID: 17525967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First experience with the BioSTAR-device for various applications in pediatric patients with congenital heart disease.
    Hoehn R; Hesse C; Ince H; Peuster M
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):72-7. PubMed ID: 19787660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The off- versus on-label use of medical devices in interventional cardiovascular medicine: clarifying the ambiguity between regulatory labeling and clinical decision-making, Part 1: PCI.
    Price MJ; Teirstein PS
    Catheter Cardiovasc Interv; 2008 Oct; 72(4):500-4. PubMed ID: 18814224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Package insert of shunt closure devices, for the doctor or for the lawyer?
    Meier B
    Catheter Cardiovasc Interv; 2009 May; 73(6):827. PubMed ID: 19367650
    [No Abstract]   [Full Text] [Related]  

  • 13. Off-label use: an industry perspective on expanding use beyond approved indications.
    Russell ME; Friedman MI; Mascioli SR; Stolz LE
    J Interv Cardiol; 2006 Oct; 19(5):432-8. PubMed ID: 17020568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Amplatzer vascular plug and Amplatzer vascular plug II for vascular occlusion procedures in 50 patients with congenital cardiovascular disease.
    Schwartz M; Glatz AC; Rome JJ; Gillespie MJ
    Catheter Cardiovasc Interv; 2010 Sep; 76(3):411-7. PubMed ID: 20552654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transhepatic therapeutic cardiac catheterization: a new option for the pediatric interventionalist.
    Shim D; Lloyd TR; Beekman RH
    Catheter Cardiovasc Interv; 1999 May; 47(1):41-5. PubMed ID: 10385157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A national survey of American Pediatric Anesthesiologists: patient-controlled analgesia and other intravenous opioid therapies in pediatric acute pain management.
    Nelson KL; Yaster M; Kost-Byerly S; Monitto CL
    Anesth Analg; 2010 Mar; 110(3):754-60. PubMed ID: 20185654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future for cardiac catheterization labs.
    Husten L
    OR Manager; 1992 May; 8(5):23. PubMed ID: 10120955
    [No Abstract]   [Full Text] [Related]  

  • 18. New directions in device therapies among children and adults with congenital heart.
    Khan A; Karpawich PP
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1683-8. PubMed ID: 21108550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical characterization of neotissues and tissue reactions to septal defect-occlusion devices.
    Foth R; Quentin T; Michel-Behnke I; Vogt M; Kriebel T; Kreischer A; Ruschewski W; Paul T; Sigler M
    Circ Cardiovasc Interv; 2009 Apr; 2(2):90-6. PubMed ID: 20031701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interventional cardiology--quo vadis?].
    Sechtem U; Erdmann E
    Dtsch Med Wochenschr; 2010 Oct; 135(39):1907. PubMed ID: 20859839
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.